Home › Therapeutic areas › Dermatology › Atopic Dermatitis
Atopic Dermatitis (13 companies)
Companies with an active program in Atopic Dermatitis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics | DermatologyRespiratory | 4 | Phase 2 | 7 |
| ALDX | Aldeyra Therapeutics | DermatologyOncology+1 Rare | 1 | NDA Submitted | 8 |
| APGE | Apogee Therapeutics | DermatologyGI/Hepatology+1 Rare | 2 | Phase 2 | 9 |
| RCUS | Arcus Biosciences | DermatologyImmunology+1 | 1 | Phase 3 | 6 |
| CLDX | Celldex Therapeutics | DermatologyImmunology+1 | 1 | Phase 3 | 7 |
| CRVS | Corvus Pharmaceuticals | DermatologyOncology | 1 | Phase 3 | 4 |
| ENTA | Enanta Pharmaceuticals | DermatologyImmunology+1 | 1 | Phase 3 | 6 |
| EVMN | Evommune | DermatologyImmunology+1 | 2 | Phase 2 | 6 |
| KYMR | Kymera Therapeutics | DermatologyRespiratory Rare | 1 | Phase 2 | 4 |
| NKTR | Nektar Therapeutics | DermatologyImmunology+2 | 1 | Phase 2 | 11 |
| TTRX | Turn Therapeutics | DermatologyInfectious Disease | 2 | Phase 3 | 4 |
| VNDA | Vanda Pharmaceuticals | CardiovascularDermatology+6 Rare | 1 | Approved | 26 |
| ZURA | Zura Bio | DermatologyImmunology Rare | 1 | Phase 2 | 4 |
No companies match.